Perspective Therapeutics, INC. (CATX) — 8-K Filings

All 8-K filings from Perspective Therapeutics, INC.. Browse 36 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (36)

Perspective Therapeutics Files 8-K — Apr 20, 2026 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on April 20, 2026, reporting other events. The filing includes various exhibits, such as financial statements and gr
Perspective Therapeutics Files 8-K — Dec 1, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on December 1, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., i
Perspective Therapeutics Files 8-K — Nov 6, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on November 6, 2025, reporting on other events and financial statements. The company, formerly known as Isoray, Inc.
Perspective Therapeutics Names New Directors, CMO Departs — Nov 3, 2025 Risk: medium
Perspective Therapeutics, Inc. announced on November 3, 2025, the departure of its Chief Medical Officer, Dr. Michael L. Lavoie. The company also reported the e
Perspective Therapeutics Files 8-K — Oct 20, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on October 20, 2025, reporting on its results of operations and financial condition, other events, and financial sta
8-K Filing — Oct 1, 2025
Perspective Therapeutics Files 8-K on Officer/Director Changes — Sep 4, 2025 Risk: medium
Perspective Therapeutics, Inc. filed an 8-K on September 4, 2025, reporting events as of September 2, 2025. The filing includes information regarding the depart
Perspective Therapeutics Files 8-K: Board, Officer, and Compensation Updates — Sep 3, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on September 3, 2025, reporting changes in its board of directors and officers, along with details on compensatory a
Perspective Therapeutics Files 8-K — Sep 2, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on September 2, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc.,
8-K Filing — Aug 1, 2025
Perspective Therapeutics Files 8-K — Jul 3, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on July 3, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is in
8-K Filing — Jun 23, 2025
Perspective Therapeutics Files 8-K — Jun 3, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on June 3, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is in
Perspective Therapeutics Files 8-K — May 30, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on May 30, 2025, reporting on other events and financial statements. The company, formerly known as Isoray, Inc., is
Perspective Therapeutics Files 8-K on Shareholder Vote Matters — May 28, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on May 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain detai
Perspective Therapeutics Files 8-K — May 1, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on May 1, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is inc
Perspective Therapeutics Files 8-K — Apr 29, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on April 29, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is
Perspective Therapeutics Files 8-K — Apr 11, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on April 11, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is
8-K Filing — Mar 26, 2025
Perspective Therapeutics Files 8-K — Mar 17, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on March 17, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as
Perspective Therapeutics, Inc. Files 8-K — Mar 4, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on March 4, 2025, reporting an event on March 3, 2025. The filing indicates a change in the company's name from Isor
Perspective Therapeutics Files 8-K — Feb 3, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on February 3, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., i
Perspective Therapeutics Files 8-K — Jan 24, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on January 24, 2025, reporting on other events and financial statements. The company, formerly known as Isoray, Inc.
Perspective Therapeutics Files 8-K — Jan 13, 2025 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition, as well as other events. The fi
Perspective Therapeutics Appoints New Chief Medical Officer — Jan 6, 2025 Risk: medium
Perspective Therapeutics, Inc. announced on January 2, 2025, the appointment of Dr. Jonathan M. Roth as Chief Medical Officer. Dr. Roth previously served as Chi
Perspective Therapeutics Files 8-K — Dec 4, 2024 Risk: medium
Perspective Therapeutics, Inc. (formerly Isoray, Inc.) filed an 8-K on December 4, 2024, reporting an event on December 3, 2024. The filing indicates a change i
Perspective Therapeutics Files 8-K — Nov 21, 2024 Risk: low
Perspective Therapeutics, Inc. (formerly IsoRay, Inc.) filed an 8-K on November 21, 2024, reporting other events and financial statements. The company, incorpor
Perspective Therapeutics Files 8-K — Nov 15, 2024 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on November 15, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known
Perspective Therapeutics Files 8-K — Oct 11, 2024 Risk: low
Perspective Therapeutics, Inc. filed an 8-K on October 11, 2024, reporting other events and financial statements. The company, formerly known as Isoray, Inc., i
Perspective Therapeutics Completes Asset Acquisition — Sep 20, 2024 Risk: medium
Perspective Therapeutics, Inc. announced on September 18, 2024, the completion of its acquisition of certain assets. The company also entered into a material de
Perspective Therapeutics to Acquire Radiactiv, Inc. — Sep 5, 2024 Risk: medium
Perspective Therapeutics, Inc. announced on September 5, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of Radiactiv, I
Perspective Therapeutics Appoints New CMO, Director — Aug 30, 2024 Risk: medium
Perspective Therapeutics, Inc. announced on August 26, 2024, the appointment of Dr. Jonathan M. Roth as Chief Medical Officer and the election of Ms. Jennifer L
Perspective Therapeutics Adds Medical Device Veteran to Board — Aug 19, 2024 Risk: low
Perspective Therapeutics, Inc. announced on August 16, 2024, the election of Dr. David W. Schramm to its Board of Directors. Dr. Schramm brings extensive experi
Perspective Therapeutics to Acquire Subsidiary IsoRay Medical — Jun 14, 2024 Risk: low
Perspective Therapeutics, Inc. announced on June 11, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of its subsidiary,
Perspective Therapeutics Files 8-K on Officer/Director Changes — May 31, 2024 Risk: medium
Perspective Therapeutics, Inc. filed an 8-K on May 31, 2024, reporting on several key events. These include the departure of directors or certain officers, the
Perspective Therapeutics Enters Material Definitive Agreement — May 29, 2024 Risk: medium
Perspective Therapeutics, Inc. announced on May 24, 2024, that it entered into a material definitive agreement. The company, formerly known as Isoray, Inc., is

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX